Russian President Vladimir Putin (left) in the pharmacy checks the prices of medicines in the course of his working trip to the Murmansk region, 2010
The President of Russia Vladimir Putin commented on the situation with medications at the meeting with the government, commenting on the report about the manipulation in this market, prepared by the Federal Antimonopoly service.
“Such manipulation in the market, particularly by manufacturers, and wholesale suppliers, they usually stimulated by unscrupulous officials of the relevant structures dealing with procurement, regulation, access to the market and so on,” Putin said (quoted by “RIA Novosti”).
“Something you can’t see any business here on this issue. I think the relevant bodies — the intelligence agencies and law enforcement bodies are obviously not doing their job”, — concluded the President. “You work with them, please closely. And we must continue this work straight. Some prices are more expensive than in Australia, and produced near us. This suggests that it is a dishonest work,” he added.
According to Putin, the price of drugs rising, despite government support. “We are for state and municipal needs allocated for these purposes of up to 400 billion rubles Is 30% of the Russian market. However, we know it too well, for 2015 there is a significant deviation in prices — up to 20%,” he said (quoted by TASS).
In August, the head of the Federal Antimonopoly service Igor Artemyev said that the price of drugs containing same substances, but sold in Russia under different trademarks, in some cases, inflated to 160 times.
As previously wrote RBC, the government decided to abandon regulation of prices for Russian vital and essential drugs (VED) cost up to 50 rubles a Corresponding letter Deputy Prime Minister Arkady Dvorkovich has sent to President. It was about such popular drugs as aspirin, ascorbic acid, glycine, Pancreatin, ibuprofen, water for injection, etc.
In February, Putin instructed the government to prevent the disappearance from the market of cheap domestic drugs included in essential drugs, and to devise measures to support producers of cheap medicines. So the President has responded to the message of pharmaceutical companies to cease production of certain drugs.
The deputies opposed the initiative of the government to cancel the regulation of prices for cheap medication. Deputies believe that “in the absence of state regulation of prices for medicines of mass consumption will be the inevitable rise in price”.